A multicentre trial of the aldose-reductase inhibitor tolrestat, in patients with symptomatic diabetic peripheral neuropathy

Diabete et Metabolisme

Volumn 18, Issue 1, 1992, Pages 14-20

  Macleod, A F ^a   Boulton, A J M ^a   Owens, D R ^a   Van Rooy, P ^a   Van Gerven, J M A ^a   Macrury, S ^a   Scarpello, J H B ^a   Segers, O ^a   Heller, S R ^a   Van Der Veen, E A ^a   Sonksen, P H ^a   Hayes, T M ^a   Tattersall, R B ^a   MacCuish, A C ^a   Somers, G ^a   De Leew, I H ^a   Lemkes, H H P K ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

aldose reductase; diabetic neuropathy; tolrestat

Indexed keywords

PLACEBO; TOLRESTAT;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC NEUROPATHY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NERVE CONDUCTION; ORAL DRUG ADMINISTRATION; PAIN; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL;

ALDEHYDE REDUCTASE; ANALYSIS OF VARIANCE; COMPARATIVE STUDY; DIABETIC NEUROPATHIES; FEMALE; HEART RATE; HEMOGLOBIN A, GLYCOSYLATED; HUMAN; MALE; MIDDLE AGE; NAPHTHALENES; NEURAL CONDUCTION; PAIN; SUPPORT, NON-U.S. GOV'T;

EID: 0026600402     PISSN: 03381684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)